Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2012
08/09/2012US20120202784 Isoindolinone inhibitors of phosphatidylinositol 3-kinase
08/09/2012US20120202783 Fused heterocyclic compounds as orexin receptor modulators
08/09/2012US20120202782 Compounds and compositions as itpkb inhibitors
08/09/2012US20120202781 Indane derivatives
08/09/2012US20120202780 Carrier composition
08/09/2012US20120202779 Management of breakthrough bleeding in extended hormonal contraceptive regimens
08/09/2012US20120202778 Use of at least one omega-3 fatty acid and of at least one polyphenol for the endogenous synthesis of eicosapentanoic acid and docosahexanoic acid
08/09/2012US20120202777 C-Linked Hydroxamic Acid Derivatives Useful As Antibacterial Agents
08/09/2012US20120202776 Phosphorus derivatives as kinase inhibitors
08/09/2012US20120202775 Substituted indole and azaindole oxoacetyl piperazinamide derivatives
08/09/2012US20120202774 Acyloxy- and phosphoryloxy-butadiene-fe(co)3 complexes as enzyme-triggered co-releasing molecules
08/09/2012US20120202773 Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising ep4 agonist as active ingredient
08/09/2012US20120202772 Cyclodextrin-based polymers for therapeutic delivery
08/09/2012US20120202771 Therapeutic agent for influenza virus infection diseases
08/09/2012US20120202770 Animal feeds and veterinary compositions
08/09/2012US20120202769 Fgf receptor-activating n-sulfate oligosaccharides, preparation thereof, and therapeutic use thereof
08/09/2012US20120202767 Hyaluronic acid based mucoadhesive therapeutic composition for the prevention and treatment of epithelial and mucosal lesions of the human body
08/09/2012US20120202766 N4-acylcytosine nucleosides for treatment of viral infections
08/09/2012US20120202765 Effective treatment of esophogeal adenocarcinoma using triciribine and related compounds
08/09/2012US20120202764 Low molecular weight pharmacological activity modulators
08/09/2012US20120202763 Methods for treating cancer and non-neoplastic conditions
08/09/2012US20120202762 Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines
08/09/2012US20120202761 Compositions and methods of improving the tolerability of daunorubicin when given as orotate salt
08/09/2012US20120202760 Methods and compositions for enhancing sensitivity of cytotoxic drugs with timely combinatorial therapy with carboxyamidotriazole orotate
08/09/2012US20120202759 Isoflavone compositions for reducing accumulation of body fat in male mammals, and methods for their use
08/09/2012US20120202758 Core 2glcnac-t inhibitors
08/09/2012US20120202757 Antihypertensive composition containing a ginsenoside-enriched fraction
08/09/2012US20120202756 Use of prodrugs to avoid gi mediated adverse events
08/09/2012US20120202755 Foliamangiferosides, preparation method and use thereof
08/09/2012US20120202753 Inhibiting inflammation with milk oligosaccharides
08/09/2012US20120202752 Antisense Oligonucleotides
08/09/2012US20120202750 Inhibitors of iap
08/09/2012US20120202742 Methods and devices for the sustained release of multiple drugs
08/09/2012US20120202738 Therapy for enteric infections
08/09/2012US20120202735 Antimicrobial cationic peptides and formulations thereof
08/09/2012US20120202732 Modified aav capsid polypeptides
08/09/2012US20120202695 Core stabilized microcapsules, method of their preparation and uses thereof
08/09/2012US20120202694 Production of encapsulated nanoparticles at commercial scale
08/09/2012US20120202692 Plant growing agent, plant disease resistance inducer, and plant disease control method
08/09/2012US20120202688 Pesticidal compositions and processes related thereto
08/09/2012US20120202687 Pesticidal compositions and processes related thereto
08/09/2012US20120201915 Therapeutic composition
08/09/2012US20120201914 Method and Composition for Improving Animal Oral Health
08/09/2012US20120201912 Substances for reducing occurrence of major cardiac events comprising omega-3 polyunsaturated fatty acid or derivatives thereof and high-monacolin k content red yeast rice extract
08/09/2012US20120201908 Method of treating bipolar disorder or depression using an antiestrogen
08/09/2012US20120201907 Nitroxyl Progenitors in the Treatment of Heart Failure
08/09/2012US20120201906 Novel medical uses for no and no donor compounds
08/09/2012US20120201901 Topical Antibiotic Formulations
08/09/2012US20120201895 Pharmaceutical Compositions
08/09/2012US20120201894 Pharmaceutical formulations for the treatment of overactive bladder
08/09/2012US20120201893 Pellets Formulation
08/09/2012US20120201892 Porous-wall hollow glass microspheres as carriers for biomolecules
08/09/2012US20120201891 Transdermal delivery patch
08/09/2012US20120201889 Modified and immediate release formulations of memantine
08/09/2012US20120201888 Pharmaceutical Compositions
08/09/2012US20120201887 Pharmaceutical Formulation
08/09/2012US20120201886 Coated Extended Release Pharmaceutical Compositions Containing Paliperidone
08/09/2012US20120201885 Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with pioglitazone
08/09/2012US20120201884 Extracts, fractions and compositions comprising acetogenins and their applications
08/09/2012US20120201883 Antiviral compositons
08/09/2012US20120201876 Method of managing hypercortisolemia, headache disorders, neuropathic pain and related disorders
08/09/2012US20120201874 Liposome Having Inner Water Phase Containing Sulfobutyl Ether Cyclodextrin Salt
08/09/2012US20120201872 Liposomes comprising a calcium phosphate-containing precipitate
08/09/2012US20120201871 Permeation enhancers with liposomes for topical formulations
08/09/2012US20120201868 Treatment and prevention of hiv infection
08/09/2012US20120201867 Drug delivery from embolic agents
08/09/2012US20120201865 Hot-melt extruded compositions containing plant-derived phenolic materials and processes for the preparation thereof
08/09/2012US20120201862 Process for the preparation of colloidal systems for the delivery of active compounds
08/09/2012US20120201859 Drug Delivery Systems and Use Thereof
08/09/2012US20120201858 Multiple-arm peptide compounds, methods of manufacture and use in therapy
08/09/2012US20120201857 Transdermal delivery system for therapeutics
08/09/2012US20120201845 Transcutaneous immunization without heterologous adjuvant
08/09/2012US20120201838 Method for screening anticancer agent or sip1/zeb2 inhibitor using integrin alpha 5
08/09/2012US20120201837 Use of eif3m for the diagnosis and treatment of cancer
08/09/2012US20120201830 Compositions and methods for treating macular edema
08/09/2012US20120201825 Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection
08/09/2012US20120201824 Compositions and Methods for Inhibiting an Oncogenic Protein to Enhance Immunogenicity
08/09/2012US20120201822 Tumor treatment
08/09/2012US20120201819 Treatment of drug-related side effect and tissue damage by targeting the cd-24-hmgb1-siglec10 axis
08/09/2012US20120201816 Lactam-containing compounds and derivatives thereof as factor xa inhibitors
08/09/2012US20120201807 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
08/09/2012US20120201803 3-substituted compounds for reducing uric acid
08/09/2012US20120201802 Method for producing reduced coenzyme q10, method for stabilizing same, and composition comprising same
08/09/2012US20120201801 Topical co-enzyme q10 formulations and methods of use
08/09/2012US20120201800 Methods and Devices for Sustained In-Vivo Release Of an Active Agent
08/09/2012US20120201794 Dual vector for inhibition of human immunodeficiency virus
08/09/2012US20120201790 Promoters exhibiting endothelial cell specificity and methods of using same
08/09/2012US20120201784 Long lasting drug formulations
08/09/2012US20120201779 Antihistamine and antihistamine-like nasal application, products
08/09/2012US20120201769 Bakuchiol compositions for treatment of post inflammatory hyperpigmentation
08/09/2012US20120201766 Topical Compositions Comprising An Alkoxylated Diphenylacrylate Compound And An Organic Nonionic Emulsifier
08/09/2012US20120201761 Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant agent
08/09/2012US20120201750 Serum biomarkers for melanoma metastasis
08/09/2012US20120201749 NP-1 Antagonists and Their Therapeutic Use
08/09/2012US20120201748 Coacervate having an ionic polymer mixed with the adhesive protein of a mussel or of a species of the variome thereof
08/09/2012US20120201747 System and Method for Diagnosis and Treatment
08/09/2012DE102011011040A1 (5s,8s)-3-(4'-Chlor-3'-fluor-4-methylbiphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-on (Verbindung A) zur Therapie (5S, 8s) -3- (4'-chloro-3'-fluoro-4-methylbiphenyl-3-yl) -4-hydroxy-8-methoxy-1-azaspiro [4.5] dec-3-en-2- one (Compound A) for the therapy
08/09/2012DE102011009470A1 Biologisch wirksame Nukleotid-Moleküle zur gezielten Abtötung von Zellen, Verwendung derselben sowie Applikationskit Biologically active nucleotide molecules for targeted killing of cells, as well as using the same application kit
08/09/2012CA2828988A1 Bicyclic heteroaryl compounds as gpr119 receptor agonists
08/09/2012CA2828570A1 Tetrahydroisoquinoline derivative
1 ... 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 ... 7860